近年，わが国を含むアジア諸国で食道胃接合部癌が増加傾向にあるといわれている．その解剖学的特異性から胸腔鏡手術や腹腔鏡手術，ロボット支援手術のような低侵襲手術には技術的困難性が高く，至適リンパ節郭清範囲や再建術の安全性も含めた適切な術式選択が必要となる．また現在，進行癌に対する集学的治療がトピックになっているが，欧米のエビデンスとは一線を画したアジア独自の集学的治療開発も必要と考えられる．本International Sessionでは，国内外から食道胃接合部癌に対する低侵襲手術および集学的治療に関する最新の知見をご報告いただき，アジアにおける展望について議論して参りたい．

In recent years, the incidence of esophagogastric junction cancer has been reported to be increasing in Asian countries, including Japan. Due to its anatomical complexity, minimally invasive surgeries such as thoracoscopic surgery, laparoscopic surgery, and robot-assisted surgery remain technically challenging, requiring careful selection of the most appropriate surgical approach, including the optimal extent of lymph node dissection and the safety of reconstruction. At present, multimodal treatment for advanced cancer has become a major topic, and there is also a need to develop treatment strategies unique to Asia that differ from the evidence established in Western countries. In this International Session, we will present the latest knowledge on minimally invasive surgery and multimodal treatment for esophagogastric junction cancer from both domestic and international experts, and discuss future perspectives in Asia.